Change
Tools: Print this page Recommend this page

Consolidated statement of income


IN € MILLIONS

1ST QUARTER

 

2010

20091

1

Restated for comparative presentation.

 

 

 

Continuing operations

 

 

Revenue

3,246

3,065

Cost of sales

(1,911)

(1,875)

Gross profit

1,335

1,190

 

 

 

Selling expenses

(772)

(733)

General and administrative expenses

(255)

(269)

Research and development expenses

(77)

(77)

Other operating income/(expenses)

(7)

(1)

Operating income

224

110

 

 

 

Financing income

12

10

Financing expenses related to pensions

(25)

(45)

Other financing expenses

(75)

(70)

Results from associates and joint ventures

5

4

Profit before tax

141

9

 

 

 

Income tax

(53)

(5)

Profit for the period from continuing operations

88

4

 

 

 

Discontinued operations

 

 

Profit for the period from discontinued operations

11

7

 

 

 

Profit for the period

99

11

 

 

 

Attributable to:

 

 

- Shareholders of the company

81

(7)

- Minority interests

18

18

 

 

 

Profit for the period

99

11

 

 

 

Earnings per share from
continuing operations (in €):

 

 

- Basic

0.30

(0.06)

- Diluted

0.30

(0.06)

 

 

 

Earnings per share from
discontinued operations (in €):

 

 

- Basic

0.05

0.03

- Diluted

0.05

0.03

 

 

 

Earnings per share from
total operations (in €):

 

 

- Basic

0.35

(0.03)

- Diluted

0.35

(0.03)

Copyright © 2010 Akzo Nobel N.V.